Travere Therapeutics
TVTX
TVTX
209 hedge funds and large institutions have $1.49B invested in Travere Therapeutics in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 76 increasing their positions, 69 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 47
16% less capital invested
Capital invested by funds: $1.77B → $1.49B (-$284M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
209
Holding in Top 10
3
Calls
$32.5M
Puts
$7.43M
Top Buyers
| 1 | +$29.8M | |
| 2 | +$14.8M | |
| 3 | +$14.5M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$12.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$11M |
Top Sellers
| 1 | -$49.6M | |
| 2 | -$46.6M | |
| 3 | -$15M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$10.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.63M |
